Volume 132, Issue 3, Pages (February 2008)

Slides:



Advertisements
Similar presentations
Volume 10, Issue 4, Pages (October 2009)
Advertisements

Volume 4, Issue 1, Pages (July 2006)
Volume 14, Issue 5, Pages (November 2011)
Volume 14, Issue 2, Pages (August 2011)
Volume 9, Issue 3, Pages (March 2009)
Volume 14, Issue 4, Pages (October 2011)
Volume 1, Issue 2, Pages (February 2005)
Volume 11, Issue 8, Pages (May 2015)
Is Energy Deficiency Good in Moderation?
Volume 7, Issue 2, Pages (February 2008)
Volume 11, Issue 1, Pages (January 2010)
Volume 22, Issue 8, Pages (February 2018)
Volume 15, Issue 4, Pages (April 2012)
Volume 16, Issue 10, Pages (September 2016)
Volume 11, Issue 3, Pages (March 2010)
Volume 7, Issue 1, Pages (January 2008)
Volume 20, Issue 4, Pages (October 2014)
Irs1 Serine 307 Promotes Insulin Sensitivity in Mice
Volume 11, Issue 5, Pages (May 2010)
Volume 11, Issue 2, Pages (February 2010)
Grzegorz Sumara, Olga Sumara, Jason K. Kim, Gerard Karsenty 
Volume 8, Issue 5, Pages (November 2008)
Volume 6, Issue 3, Pages (September 2007)
Volume 7, Issue 5, Pages (May 2001)
Volume 6, Issue 3, Pages (September 2007)
Volume 22, Issue 3, Pages (March 2015)
Volume 21, Issue 11, Pages (December 2017)
IRS1-Independent Defects Define Major Nodes of Insulin Resistance
Antidiabetic Effects of IGFBP2, a Leptin-Regulated Gene
Metabolic Stress Signaling Mediated by Mixed-Lineage Kinases
Volume 15, Issue 5, Pages (May 2012)
Volume 18, Issue 13, Pages (March 2017)
Volume 7, Issue 4, Pages (May 2014)
Volume 20, Issue 1, Pages (July 2014)
Volume 9, Issue 3, Pages (March 2009)
Volume 15, Issue 3, Pages (March 2008)
Antidiabetic Effects of IGFBP2, a Leptin-Regulated Gene
Volume 17, Issue 10, Pages (December 2016)
Regulation of Hepatic Energy Metabolism and Gluconeogenesis by BAD
Volume 13, Issue 3, Pages (March 2011)
Volume 22, Issue 6, Pages (June 2015)
Circadian Disruption Leads to Insulin Resistance and Obesity
Volume 23, Issue 6, Pages (June 2016)
Volume 16, Issue 4, Pages (October 2012)
Volume 6, Issue 4, Pages (October 2007)
Volume 10, Issue 1, Pages (July 2009)
Volume 8, Issue 4, Pages (October 2008)
Volume 21, Issue 5, Pages (May 2015)
Volume 9, Issue 4, Pages (November 2014)
Volume 5, Issue 5, Pages (May 2007)
Volume 1, Issue 4, Pages (April 2005)
Volume 24, Issue 8, Pages e7 (August 2018)
Volume 22, Issue 2, Pages (August 2015)
Volume 15, Issue 5, Pages (May 2012)
Volume 6, Issue 1, Pages (July 2007)
Volume 6, Issue 3, Pages (September 2007)
Volume 14, Issue 5, Pages (November 2011)
Volume 8, Issue 5, Pages (November 2008)
Volume 12, Issue 6, Pages (December 2010)
Cardiotrophin-1 Is a Key Regulator of Glucose and Lipid Metabolism
Identification of SH2-B as a key regulator of leptin sensitivity, energy balance, and body weight in mice  Decheng Ren, Minghua Li, Chaojun Duan, Liangyou.
Volume 14, Issue 2, Pages (August 2011)
Volume 22, Issue 2, Pages (August 2015)
Mice with AS160/TBC1D4-Thr649Ala Knockin Mutation Are Glucose Intolerant with Reduced Insulin Sensitivity and Altered GLUT4 Trafficking  Shuai Chen, David.
Volume 6, Issue 4, Pages (October 2007)
Lipin, a lipodystrophy and obesity gene
Volume 4, Issue 5, Pages (November 2006)
Volume 2, Issue 2, Pages (August 2005)
Volume 5, Issue 6, Pages (June 2007)
Volume 26, Issue 1, Pages 1-10.e7 (January 2019)
Presentation transcript:

Volume 132, Issue 3, Pages 375-386 (February 2008) Downregulation of Diacylglycerol Kinase Delta Contributes to Hyperglycemia-Induced Insulin Resistance  Alexander V. Chibalin, Ying Leng, Elaine Vieira, Anna Krook, Marie Björnholm, Yun Chau Long, Olga Kotova, Zhihui Zhong, Fumio Sakane, Tatiana Steiler, Carolina Nylén, Jianjun Wang, Markku Laakso, Matthew K. Topham, Marc Gilbert, Harriet Wallberg-Henriksson, Juleen R. Zierath  Cell  Volume 132, Issue 3, Pages 375-386 (February 2008) DOI: 10.1016/j.cell.2007.12.035 Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 1 Skeletal Muscle DGKδ Protein Expression and DGK Activity Is Reduced in Type 2 Diabetic Patients and Hyperglycemic Diabetic GK Rats (A and B) Skeletal muscle lysates from type 2 diabetic (n = 11) and nondiabetic (n = 11) participants were subjected to immunoblot analysis using an antibody against DGKδ (A). Upper panel is representative image and lower panel is mean ± SEM, arbitrary units. ∗p < 0.05 versus control. Representative immunoblot analysis (B) for DGKα, DGKɛ, DGKζ, and actin (loading control) is shown. (C) Total DGK activity in skeletal muscle homogenates from type 2 diabetic and controls. Upper panel is representative autoradiogram of phosphatidic acid (PA) production, lower panel mean ± SEM, arbitrary units. (D) DGKδ and DGKζ protein expression in primary human myotubes exposed to 5.5 or 25 mM glucose. ∗p < 0.05 versus 5.5 mM glucose. (E–G) Gastrocnemius muscle from Wistar and GK rats after 4 week treatment with phlorizin (phl) or saline (n = 5–6 rats). Shown are DGKδ and actin protein expression (E), Total DGK activity (F), DAG content (G). ∗p < 0.05 versus Wistar. (H) DGKδ protein in gastrocnemius muscle from Wistar rats fed chow or high-fat diet for 4 weeks. ∗p < 0.05 versus chow-fed. For (D)–(H), upper panel is representative image and lower panel mean ± SEM, arbitrary units. Cell 2008 132, 375-386DOI: (10.1016/j.cell.2007.12.035) Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 2 DGK Inhibition Attenuates Insulin Action in Rat Muscle Isolated epitrochlearis muscle (n = 6–11) was incubated in the absence or in presence of 2.4 nM insulin and/or 25 μM R59949, 50 μM R59022, and/or 1 μM of PMA. Muscle homogenates were prepared for (A) total DGK activity, (B) DAG content, and (C) combined conventional and novel PKC activity analysis. Lysates were subjected to immunoblot analysis for (D) PKCδ Thr505 phosphorylation, (E) IR tyrosine phosphorylation, (F) IRS-1 Ser307 phosphorylation, and (G) IRS-1 Ser302 phosphorylation. Skeletal muscle was also incubated (H–I) in the absence or presence of 1 μM PMA, 1 μM GF109203X, 25 μM R59949, or 50 μM R59022. (H) IRS-1 tyrosine phosphorylation, PI 3-kinase activity, Akt Ser473 phosphorylation, and (I–J) 3-O-methyl-glucose transport were assessed. Upper panel is representative image. Lower panel is mean ± SEM, ∗p < 0.05 versus non-insulin-stimulated control. #p < 0.05 versus insulin-stimulated. Cell 2008 132, 375-386DOI: (10.1016/j.cell.2007.12.035) Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 3 DGK Protein Expression and Activity in DGKδ Haploinsufficient Mice (A–C) DGKδ protein expression in (A) gastrocnemius muscle, (B) epidydimal fat, and (C) liver in DGKδ+/− mice versus WT mice at 9 weeks of age. (D) Total DGK activity, per gram of tissue protein, in homogenates prepared from gastrocnemius muscle, epidydimal fat, and liver. (E) Total DGK activity per gram of tissue protein in homogenate (Hom), crude membrane fraction (Membr), and cytoplasmic (Cyto) fraction isolated from gastrocnemius muscle from 9-week-old DGKδ+/− mice. Results are mean ± SEM for n = 7–15 animals. ∗p < 0.05 versus 9-week-old WT mice. Cell 2008 132, 375-386DOI: (10.1016/j.cell.2007.12.035) Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 4 DGKδ Haploinsufficiency Leads to Glucose Intolerance and Obesity (A) Body weight and epidydimal fat pad weight of DGKδ+/− and WT mice at 9 and 36 weeks. (B and C) Glucose (B) and insulin (C) during glucose tolerance in overnight fasted mice. (D) Skeletal muscle lysates were subjected to immunoblot analysis using an antibody against DGKδ. Upper panel is representative image and lower panel is mean ± SEM, arbitrary units. ∗p < 0.05 versus WT. (E and F) Total DGK activity (E) and DAG content (F) in skeletal muscle homogenate. Results are mean ± SEM. (G) Basal and insulin-stimulated in vitro 2-deoxyglucose uptake in isolated soleus muscle from WT and DGKδ+/− mice. Results are mean ± SEM for 8–12 mice. ∗p < 0.05 versus WT mice at 9 weeks, #p < 0.05 versus WT mice at 36 weeks. Cell 2008 132, 375-386DOI: (10.1016/j.cell.2007.12.035) Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 5 DGKδ Haploinsufficiency Impairs Peripheral Insulin Sensitivity and Signaling (A and B) In vivo glucose utilization during euglycemic-hyperinsulinemic clamp under low (A; 1.25 mU/min/kg) or high (B; 10 mU/min/kg) dose insulin infusion in 9-week-old DGKδ+/− and WT mice. (C and D) In vivo insulin-stimulated glucose uptake in (C) skeletal and cardiac muscle (D) and subcutaneous (SubqAT), epidydimal (EpiAT), and brown adipose tissues (BAT) after high-dose insulin infusion. (E and F) Insulin signal transduction in skeletal muscle (E) or liver (F) measured after high-dose insulin infusion. Upper panel is representative image and lower panel is mean ± SEM, arbitrary units. Results are mean ± SEM for n = 7–9 mice. ∗p < 0.05 versus WT mice. Cell 2008 132, 375-386DOI: (10.1016/j.cell.2007.12.035) Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 6 Skeletal Muscle Lipid Oxidation and Whole-Body Energy Homeostasis Impairments in DGKδ+/− Mice (A) Oleate oxidation in isolated soleus muscle from fed DGKδ+/− and WT mice. (B) Food intake assessed over 24 hr. (C) Locomotor activity assessed over 24 hr. (D) Whole-body oxygen consumption (VO2) assessed over 24 hr. (E) Respiratory exchange ratio assessed over 24 hr, during the light (sedentary) and dark (active) cycles. Results are mean ± SEM, ∗p < 0.05 versus WT mice. Cell 2008 132, 375-386DOI: (10.1016/j.cell.2007.12.035) Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 7 Signaling Impairments in Gastrocnemius Muscle from DGKδ+/− Mice (A–D) Muscle lysates were subjected to immunoblot analysis for (A) PKCδ Thr505 phosphorylation, (B) IR protein and actin (loading control), (C and D) IRS-1 protein/IRS-1 Ser307 phosphorylation in W mice and DGKδ+/− mice at 9 and 36 weeks. Upper panel shows representative image. Graphs are mean ± SEM, ∗p < 0.05 versus 9-week-old WT mice. Cell 2008 132, 375-386DOI: (10.1016/j.cell.2007.12.035) Copyright © 2008 Elsevier Inc. Terms and Conditions